The global human liver models size was USD 2.0 Billion in 2020 and is expected to register a robust CAGR of 13.9%. Growing incidence of live diseases, cancer, non-alcoholic fatty liver disorders, and increasing research of these diseases are some crucial factors boosting demand for liver models.